Lapidos, KA, Kakkar, R. & Mcnally, EM The dystrophin glycoprotein complex. Circ. Res. 941023-1031 (2004).
Google Scholar
Verhaart, IEC & Aartsma-Rus, A. Therapeutic developments for Duchenne muscular dystrophy. Nat. Rev. Neurol. 15373–386 (2019).
Google Scholar
Matthews, E., Brassington, R., Kuntzer, T., Jichi, F. & Manzur, AY Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database System Rev. 5CD003725 (2016).
Yusuf, S. et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N.Engl. J.Med. 325293–302 (1991).
Google Scholar
Bourke, JP et al. Randomized placebo-controlled trial of a combination of ACE inhibitors and beta-blockers to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Cardiac Protection Study): A protocol study. BMJ open 8e022572 (2018).
CIBIS-II investigators and committees. The Bisoprolol Heart Failure Study II (CIBIS-II): A Randomized Trial. Lancet 3539–13 (1999).
Google Scholar
MacMahon, S. et al. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet 349375–380 (1997).
Google Scholar
Kieny, P. et al. Evolution of the life expectancy of patients with Duchenne muscular dystrophy at the AFM Yolaine center in Kepper between 1981 and 2011. Ann. Phys. Rehabilit. Med. 56443–454 (2013).
Google Scholar
Seguchi, O. et al. Heart transplantation improves ambulation ability in patients with muscular dystrophy – an analysis of 9 cases. Circ. J 83684–686 (2019).
Google Scholar
Grady, RM et al. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model of Duchenne muscular dystrophy. Cell 90729–738 (1997).
Google Scholar
Nakamura, K. et al. Generation of rat models of muscular dystrophy with a CRISPR/Cas system. Science. representing 45635 (2014).
Sugihara, H. et al. Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy. Science. representing 416385 (2014).
Sugihara, H. et al. Echocardiographic and pathological findings as a function of age in a rat model with Duchenne muscular dystrophy generated by CRISPR/Cas9 genome editing. Int. J-heart 611279-1284 (2020).
Google Scholar
Miyamoto, M. et al. Cardiac lesions in model rats of Duchenne muscular dystrophy with out-of-frame Dmd gene mutation mediated by the CRISPR/Cas9 system. J. Toxicol. Pathol. 33227-236 (2020).
Google Scholar
Harvey, DC, Schofield, CJ, Williden, GM, and McQuillan, JA The effect of medium-chain triglycerides on the timing of nutritional ketosis and symptoms of keto-induction in healthy adults: a randomized controlled clinical trial. J. Nutr. Metab. 20182630565 (2018).
Google Scholar
Neal, EG et al. The ketogenic diet for the treatment of childhood epilepsy: a randomized controlled trial. Neurol lancet. seven500–506 (2008).
Google Scholar
Augustine, K. et al. Mechanisms of action of the medium chain triglyceride ketogenic diet in neurological and metabolic disorders. Neurol lancet. 1784–93 (2018).
Google Scholar
Staffstrom, CE & Rho, JM The ketogenic diet as a treatment paradigm for various neurological disorders. Front. Pharmacol. 359 (2012).
Google Scholar
Nakao, R., Abe, T., Yamamoto, S. & Oishi, K. The ketogenic diet induces skeletal muscle atrophy by reducing muscle protein synthesis and possibly activating proteolysis in mice. Science. representing 919652 (2019).
Tinsley, GM & Willoughby, DS Changes in fat-free mass during ketogenic diets and the potential role of resistance training. Int. J. Sport Nutr. Exercise Metab. 2678–92 (2016).
Google Scholar
Huttenlocher, PR, Wilbourn, AJ & Signore, JM Medium-chain triglycerides as a treatment for refractory childhood epilepsy. Neurology 211097-1103 (1971).
Google Scholar
Fujikura, Y., Sugihara, H., Hatakeyama, M., Oishi, K. & Yamanouchi, K. The ketogenic diet with medium-chain triglycerides restores skeletal muscle function and pathology in a rat model of dystrophy Duchenne muscle. Faseb J. 35e21861 (2021).
Nakamura, M. et al. Dietary carbohydrate restriction inhibits the development of cardiac enlargement and heart failure. Cardiovascular. Res. 1172365–2376 (2020).
Google Scholar
Yu, Y., Wang, F., Wang, J., Zhang, D., and Zhao, X. The ketogenic diet attenuates myocardial remodeling and dysfunction associated with aging in mice. Exp. Gerontol. 140111058 (2020).
Google Scholar
Okere, IC et al. A low-carbohydrate, high-fat diet attenuates cardiac enlargement, remodeling, and altered gene expression in hypertension. Hypertension 481116-1123 (2006).
Google Scholar
Sharma, N. et al. Diets high in sugar increase cardiac dysfunction and mortality in hypertension compared to diets low in carbohydrates or high in starch. J. Hypertens. 261402–1410 (2008).
Google Scholar
Duda, MK et al. A low-carbohydrate, high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction. J.Card. Fail. 14327-335 (2008).
Google Scholar
Nielsen, R. et al. Cardiovascular effects of 3-hydroxybutyrate ketone body treatment in patients with chronic heart failure. Traffic 1392129-2141 (2019).
Google Scholar
Heydemann, A. Skeletal muscle metabolism in Duchenne and Becker muscular dystrophy – implications for therapies. Nutrients ten796 (2018).
Burell, Y. et al. Alterations in mitochondrial function as a precursor to cardiomyopathy: lessons from the dystrophic heart. J.Mol. Cell. Cardole. 48310-321 (2010).
Google Scholar
Montaigne, D., Butruille, L. & Staels, B. PPAR control of metabolism and cardiovascular functions. Nat. Rev. Cardiol. 12809–823 (2021).
Google Scholar
Moroni, J. et al. Acceleration of Mdx cardiac histopathology by physical exercise. Life Basel 11706 (2021).
Google Scholar
Hourde, C. et al. Voluntary physical activity protects against susceptibility to skeletal muscle contraction-induced injury but worsens cardiac function in mdx mice. A m. J. Pathol. 1821509-1518 (2013).
Google Scholar
Diegoli, M. et al. Diagnostic workup and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin abnormalities. Jam. Coll. Cardole. 58925–934 (2011).
Google Scholar
Bergmann, O. et al. Dynamics of cell generation and renewal in the human heart. Cell 1611566-1575 (2015).
Google Scholar
Toko, H. et al. Omega-3 fatty acid prevents the development of heart failure by changing the fatty acid composition of the heart. Science. representing ten15553 (2020).
Google Scholar
Nelson, JR & Raskin, S. The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease. Postgraduate. Med. 131268-277 (2019).
Google Scholar
Simopoulos, AP The importance of the omega-6/omega-3 essential fatty acid ratio. Biomedical. Pharmacologist. 56365–379 (2002).
Google Scholar
Mauricio, AF, Pereira, JA, Santo Neto, H. & Marques, MJ Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on the hearts of dystrophic mdx mice at later stages of dystrophy . Nutrition 32855–862 (2016).
Google Scholar
C. de Lucia, et al. Echocardiographic stress analysis for the early detection of left ventricular systolic/diastolic dysfunction and dyssynchrony in a mouse model of physiological aging. J. Gerontol. A Biol. Science. Med. Science. 74455–461 (2019).
Google Scholar
Bauer, M. et al. Strain imaging based on speckle echocardiographic monitoring for rapid cardiovascular phenotyping in mice. Circ. Res. 108908–916 (2011).
Google Scholar
Du Sert, NP et al. Reporting Animal Research: Explaining and Developing ARRIVE 2.0 Guidelines. PLoS Biol. 18e3000410 (2020).
American Veterinary Medical Association. AVMA Euthanasia Guidelines, 2020 Edition, https://www.avma.org/sites/default/files/2020-02/Guidelines-on-Euthanasia-2020.pdf (2020).